Form4insider filings, from the source

SEC Form 4 · accession 0000899243-18-007252

Corvus Pharmaceuticals, Inc. · CRVS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Terry P Gould
Director · 10% Owner
Period of report
Mar 12, 2018
Accepted (ET)
Mar 13, 2018 · 4:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001626971

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, $0.0001 par valueF2Mar 12, 2018P69,864$8.50A69,864IBy Fund
Common Stock, $0.0001 par valueF4Mar 12, 2018P236,128$8.50A236,128IBy Fund
Common Stock, $0.0001 par valueF6Mar 12, 2018P67,769$8.50A67,769IBy Fund
Common Stock, $0.0001 par valueF8Mar 12, 2018P87,668$8.50A87,668IBy Fund
Common Stock, $0.0001 par valueF10Mar 12, 2018P126,806$8.50A126,806IBy Fund
Common Stock, $0.0001 par valueF11,F12holding———2,687,381IBy Funds

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses